Christophe Acar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christophe Acar has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Emmanuel Lansac
Department of Cardiac Surgery, Institut Mutualiste Montsouris, Paris, France
2 shared publications - Didier Chatel
Clinique Saint Gatien, Tours, France
1 shared publication Dominique Blin
CHU Michallon, Grenoble, France
1 shared publicationE Lansac
1 shared publicationEmmanuel Lansac
Department of Cardiovascular Surgery, Hôpital de la Salpétrière, 50-52 Bd Vincent Auriol, 75013 Paris, France
1 shared publicationEric Arnaud Crozat
Clinique Belledone, Saint Martin d’Hères, France
1 shared publication
Latest Publications
- 31 January 2010
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 2 (1) , 107
327 A standardized approach of aortic valve sparing combining root remodeling and aortic annuloplasty: impact of additional cusp repair?
- 31 January 2010
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 2 (1) , 107
327 A standardized approach of aortic valve sparing combining root remodeling and aortic annuloplasty: impact of additional cusp repair?
- 1 August 2005
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 80 (2) , 494
Invited commentary
- 1 August 2005
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 80 (2) , 494
Invited commentary
- Open Access
- 1 December 2004
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 26 (6) , 1112-1117
Ischemic mitral valve prolapse: mechanisms and implications for valve repair
Objective: The aim of this study was to assess the mechanisms of prolapse in ischemic mitral valve regurgitation (MR) and the techniques of valve repair. Methods: Out of 121 patients operated upon for ischemic MR, a prolapse was present in 44 patients (36.4%). The operation was performed emergently in four cases (9.1%) and electively in 40 patients (90.9%). Fifteen patients (34.1%) were operated upon within 60 days following acute myocardial infarction. Results: The diagnosis of prolapse had been overlooked by echography in five cases (11.4%). A commissural area was involved as the site of prolapse in 31 cases (70.4%). The mechanism of prolapse was a papillary muscle (PM) lesion in 38 cases (86.4%) (anterior PM: n=8, posterior PM n=36) or a chordal lesion in six cases (13.6%). PM injury was elongation (n=16), or rupture (total n=1, partial n=21, incomplete n=4). The operative technique was mitral valve repair with Carpentier's techniques in 42 cases (95.5%) or replacement in two cases (4.5%). Hospital mortality was 11.4% (n=4). The mean follow-up was to 44.7±29.6 months. Overall survival and freedom from reoperation were 68.3±9.0 and 89.9±5.7% at 5 years, respectively. Freedom from MR equal or ≫ grade 2 was 69.7±9.5% at 5 years. Conclusions: The mechanisms of ischemic mitral valve prolapse were variable and tightly linked to the PM anatomy. A reliable mitral valve repair could be achieved in most cases with acceptable mid-term results.
- 1 December 2004
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 26 (6) , 1112-1117
Open AccessIschemic mitral valve prolapse: mechanisms and implications for valve repair
Objective: The aim of this study was to assess the mechanisms of prolapse in ischemic mitral valve regurgitation (MR) and the techniques of valve repair. Methods: Out of 121 patients operated upon for ischemic MR, a prolapse was present in 44 patients (36.4%). The operation was performed emergently in four cases (9.1%) and electively in 40 patients (90.9%). Fifteen patients (34.1%) were operated upon within 60 days following acute myocardial infarction. Results: The diagnosis of prolapse had been overlooked by echography in five cases (11.4%). A commissural area was involved as the site of prolapse in 31 cases (70.4%). The mechanism of prolapse was a papillary muscle (PM) lesion in 38 cases (86.4%) (anterior PM: n=8, posterior PM n=36) or a chordal lesion in six cases (13.6%). PM injury was elongation (n=16), or rupture (total n=1, partial n=21, incomplete n=4). The operative technique was mitral valve repair with Carpentier's techniques in 42 cases (95.5%) or replacement in two cases (4.5%). Hospital mortality was 11.4% (n=4). The mean follow-up was to 44.7±29.6 months. Overall survival and freedom from reoperation were 68.3±9.0 and 89.9±5.7% at 5 years, respectively. Freedom from MR equal or ≫ grade 2 was 69.7±9.5% at 5 years. Conclusions: The mechanisms of ischemic mitral valve prolapse were variable and tightly linked to the PM anatomy. A reliable mitral valve repair could be achieved in most cases with acceptable mid-term results.
- 1 September 2004
- Vol. 13 (5) , 741-6
Anterior leaflet augmentation with autologous pericardium for mitral repair in rheumatic valve insufficiency.
The mechanism of insufficiency in rheumatic valve disease includes annulus dilatation and restricted leaflet motion. In order to improve the treatment of restriction, the anterior mitral leaflet (AML) can be augmented with a piece of glutaraldehyde-treated autologous pericardium. Between January 1995 and December 1999, among 274 patients referred for rheumatic mitral disease, 143 (52%) underwent a valve repair. Of these patients, 81% had pure regurgitation and 19% had significant associated stenosis. Ring annuloplasty was used in all cases. Techniques used to treat the restrictive component of the regurgitation were compared in two consecutive cohorts of patients, either with (n = 62) or without (n = 81) AML augmentation. Mean patient age was 42 +/- 3 years, and all preoperative variables were comparable except for the incidence of redo patients, who all underwent AML extension. In-hospital mortality was 0.7% (n = 1 with AML extension), and there was one early reoperation for pericardial patch dehiscence. After a mean follow up of 3.2 years, there was one sudden death (no AML extension). The reoperation rate was lower with (2.5%) than without (12.9%) AML augmentation (p <0.05). Echocardiography showed a lower incidence in recurrence of mitral insufficiency when AML augmentation was performed (grade 2, 9% versus grade 3, 3%) as compared to no AML augmentation (grade 2, 35% versus grade 3, 14%) (p <0.05). The mitral orifice area was larger (AML augmentation 2.2 +/- 0.3 cm versus no AML augmentation 1.8 +/- 0.4 cm2). Ring annuloplasty alone failed to correct rheumatic mitral insufficiency in all cases. AML augmentation improved the quality of the repair, and decreased the risk of reoperation.
- 1 September 2004
- Vol. 13 (5) , 741-6
Anterior leaflet augmentation with autologous pericardium for mitral repair in rheumatic valve insufficiency.
The mechanism of insufficiency in rheumatic valve disease includes annulus dilatation and restricted leaflet motion. In order to improve the treatment of restriction, the anterior mitral leaflet (AML) can be augmented with a piece of glutaraldehyde-treated autologous pericardium. Between January 1995 and December 1999, among 274 patients referred for rheumatic mitral disease, 143 (52%) underwent a valve repair. Of these patients, 81% had pure regurgitation and 19% had significant associated stenosis. Ring annuloplasty was used in all cases. Techniques used to treat the restrictive component of the regurgitation were compared in two consecutive cohorts of patients, either with (n = 62) or without (n = 81) AML augmentation. Mean patient age was 42 +/- 3 years, and all preoperative variables were comparable except for the incidence of redo patients, who all underwent AML extension. In-hospital mortality was 0.7% (n = 1 with AML extension), and there was one early reoperation for pericardial patch dehiscence. After a mean follow up of 3.2 years, there was one sudden death (no AML extension). The reoperation rate was lower with (2.5%) than without (12.9%) AML augmentation (p <0.05). Echocardiography showed a lower incidence in recurrence of mitral insufficiency when AML augmentation was performed (grade 2, 9% versus grade 3, 3%) as compared to no AML augmentation (grade 2, 35% versus grade 3, 14%) (p <0.05). The mitral orifice area was larger (AML augmentation 2.2 +/- 0.3 cm versus no AML augmentation 1.8 +/- 0.4 cm2). Ring annuloplasty alone failed to correct rheumatic mitral insufficiency in all cases. AML augmentation improved the quality of the repair, and decreased the risk of reoperation.
- 1 September 2004
- Vol. 97 (9) , 875-80
[Widening plasty of the anterior cusp in rheumatic mitral insufficiency].
The mechanism of insufficiency in rheumatic valve disease includes 1. annulus dilatation and 2. restricted leaflet motion. Aiming at improving the treatment of restriction, augmentation of the anterior mitral leaflet (AML) was achieved with a piece of autologous pericardium. between January 1995 and December 1999, out of 274 patients refered for rheumatic mitral disease, 143 patients underwent a repair (52%), 81% of them had pure regurgitation with no stenosis. Ring annuloplasty was performed in all cases. Two techniques used for treating the restrictive componant of the regurgitation were compared in two consecutive cohort of patients: no AML augmentation (n=62) and AML augmentation (n=81). Mean age was 42 + 3 years and all preoperative variables were comparable except for the incidence of redo patients who all underwent AML extension. in hospital mortality was 0.7% (n=1 with AML extension) and there was one early reoperation for a pericardial patch dehiscence. After a mean follow-up of 3.2 years, there was one sudden death (no AML extension). The reoperation rate was lower with (2.5%) than without (12.9%) AML augmentation (p<0.05). Echographic study showed a lower incidence of recurrency of mitral insufficiency when AML augmentation had been performed (grade 2: 9% and grade 3: 3%) as compared to no AML augmentation (grade 2: 35% and grade 3: 14%) (p<0.05). The mitral orifice area was larger (AML augmentation: 2.2 + 0.3 cm2 vs no AML augmentation: 1.8 + 0.4 cm2). ring annuloplasty alone failed to correct rheumatic mitral insufficiency in all cases. AML augmentation improved the quality of the repair and decreased the risk of reoperation.
- 1 September 2004
- Vol. 97 (9) , 875-80
[Widening plasty of the anterior cusp in rheumatic mitral insufficiency].
The mechanism of insufficiency in rheumatic valve disease includes 1. annulus dilatation and 2. restricted leaflet motion. Aiming at improving the treatment of restriction, augmentation of the anterior mitral leaflet (AML) was achieved with a piece of autologous pericardium. between January 1995 and December 1999, out of 274 patients refered for rheumatic mitral disease, 143 patients underwent a repair (52%), 81% of them had pure regurgitation with no stenosis. Ring annuloplasty was performed in all cases. Two techniques used for treating the restrictive componant of the regurgitation were compared in two consecutive cohort of patients: no AML augmentation (n=62) and AML augmentation (n=81). Mean age was 42 + 3 years and all preoperative variables were comparable except for the incidence of redo patients who all underwent AML extension. in hospital mortality was 0.7% (n=1 with AML extension) and there was one early reoperation for a pericardial patch dehiscence. After a mean follow-up of 3.2 years, there was one sudden death (no AML extension). The reoperation rate was lower with (2.5%) than without (12.9%) AML augmentation (p<0.05). Echographic study showed a lower incidence of recurrency of mitral insufficiency when AML augmentation had been performed (grade 2: 9% and grade 3: 3%) as compared to no AML augmentation (grade 2: 35% and grade 3: 14%) (p<0.05). The mitral orifice area was larger (AML augmentation: 2.2 + 0.3 cm2 vs no AML augmentation: 1.8 + 0.4 cm2). ring annuloplasty alone failed to correct rheumatic mitral insufficiency in all cases. AML augmentation improved the quality of the repair and decreased the risk of reoperation.